People · Operator

Ann Bordelon

Named in public records as an officer, director or promoter · active 2016–2016 · Other Health Care

1
Companies
1
Filings
$52.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NOWDiagnostics, Inc.Other Health CareSeries B$52.3M$420.4M2016
Operator network

Ann Bordelon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Clete Brewer · 8 companies · 1 sharedClete BrewerAlan Chang · 4 companies · 1 sharedAlan ChangKevin Clark · 4 companies · 1 sharedKevin ClarkJeremy Wilson · 3 companies · 1 sharedJeremy WilsonChuck Farkas · 2 companies · 1 sharedChuck FarkasDoug Degn · 2 companies · 1 sharedDoug DegnCharles B. Farkas · 1 companies · 1 sharedCharles B. FarkasDoug B. Degn · 1 companies · 1 sharedDoug B. DegnGerald Gallwas · 1 companies · 1 sharedGerald GallwasGerald Galwas · 1 companies · 1 sharedGerald GalwasJeff B. Montie · 1 companies · 1 sharedJeff B. MontieJeff Montie · 1 companies · 1 sharedJeff MontieJerry Galwns · 1 companies · 1 sharedJerry GalwnsJohn B. Harley · 1 companies · 1 sharedJohn B. HarleyJohn Harley · 1 companies · 1 sharedJohn HarleyQinwei Shi · 1 companies · 1 sharedQinwei ShiNOWDiagnostics, Inc. · $52.3M raisedNOWDiagnostics, Inc.Ann BordelonAB
Ann Bordelon Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Ann Bordelon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Clete Brewer18
Kevin Clark14
Alan Chang14
Jeremy Wilson13
Doug Degn12
Chuck Farkas12
Gerald Galwas11
Jeff Montie11
Doug B. Degn11
Gerald Gallwas11
John Harley11
Charles B. Farkas11
John B. Harley11
Jeff B. Montie11
Qinwei Shi11
Jerry Galwns11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.